Ami Izawa

Yokohama, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Valid surrogate end-points in nonsmall cell lung cancer peri-operative systemic therapy trials: a systematic review.

Valid surrogate end-points in nonsmall cell lung cancer peri-operative systemic therapy trials: a systematic review.

Journal: European respiratory review : an official journal of the European Respiratory Society

Published: February 19, 2025

Rapid detection of non-small cell lung cancer driver mutations using droplet digital polymerase chain reaction analysis of bronchial washings: a prospective multicenter study.

Rapid detection of non-small cell lung cancer driver mutations using droplet digital polymerase chain reaction analysis of bronchial washings: a prospective multicenter study.

Journal: Translational lung cancer research

Published: August 29, 2024

Efficacy and safety of benralizumab in elderly patients with severe eosinophilic asthma.

Efficacy and safety of benralizumab in elderly patients with severe eosinophilic asthma.

Journal: European clinical respiratory journal

Published: July 30, 2024

HLA-DQA101:03 and DQB106:01 are risk factors for severe COVID-19 pneumonia.

HLA-DQA101:03 and DQB106:01 are risk factors for severe COVID-19 pneumonia.

Journal: HLA

Published: February 26, 2024

Improved diagnostic accuracy with three lung tumor markers compared to six-marker panel.

Improved diagnostic accuracy with three lung tumor markers compared to six-marker panel.

Journal: Translational lung cancer research

Published: January 11, 2024

ILD-GAP combined with the monocyte ratio could be a better prognostic prediction model than ILD-GAP in patients with interstitial lung diseases.

ILD-GAP combined with the monocyte ratio could be a better prognostic prediction model than ILD-GAP in patients with interstitial lung diseases.

Journal: BMC pulmonary medicine

Published: August 06, 2023

Serum heme oxygenase-1 as a prognostic biomarker in patients with acute exacerbation of interstitial lung disease.

Serum heme oxygenase-1 as a prognostic biomarker in patients with acute exacerbation of interstitial lung disease.

Journal: Scientific reports

Published: July 28, 2023

Adverse events induced by durvalumab and tremelimumab combination regimens: a systematic review and meta-analysis.

Adverse events induced by durvalumab and tremelimumab combination regimens: a systematic review and meta-analysis.

Journal: Therapeutic advances in medical oncology

Published: April 04, 2023

Whole-Genome Sequencing Predicting Phenotypic Antitubercular Drug Resistance: Meta-analysis.

Whole-Genome Sequencing Predicting Phenotypic Antitubercular Drug Resistance: Meta-analysis.

Journal: The Journal of infectious diseases

Published: March 27, 2023

ILD-GAP Combined with the Charlson Comorbidity Index Score (ILD-GAPC) as a Prognostic Prediction Model in Patients with Interstitial Lung Disease.

ILD-GAP Combined with the Charlson Comorbidity Index Score (ILD-GAPC) as a Prognostic Prediction Model in Patients with Interstitial Lung Disease.

Journal: Canadian respiratory journal

Published: October 06, 2022

Clinical importance of serum heme oxygenase-1 measurement in patients with acute exacerbation of idiopathic pulmonary fibrosis triggered by coronavirus disease 2019.

Clinical importance of serum heme oxygenase-1 measurement in patients with acute exacerbation of idiopathic pulmonary fibrosis triggered by coronavirus disease 2019.

Journal: Respiratory medicine case reports

Published: November 30, 2021

Diagnostic utility of transbronchial biopsy for Hodgkin's lymphoma: A case study.

Diagnostic utility of transbronchial biopsy for Hodgkin's lymphoma: A case study.

Journal: Thoracic cancer

Published: August 31, 2021

Showing 1-12 of 13

Last Updated: 09/26/2026